Second Primary Tumor Status
Clinical Parameters
None
HNSCC
Lung/ Oesophagus
Remote
p –value*
Age
<65
172 (81%)
18 (8%)
9 (4%)
14 (7%)
0.230
>65
123 (82%)
10 (7%)
12 (8%)
5 (3%)
Sex
Male
188 (80%)
22 (9%)
14 (6%)
11 (5%)
0.086
Female
107 (84%)
6 (5%)
7 (5%)
8 (6%)
Index Tumour Stage†
1
87 (85%)
5 (5%)
6 (6%)
4 (4%)
0.784
2
123 (79%)
16 (10%)
9 (6%)
3
62 (82%)
4 (5%)
6 (8%)
4
21 (75%)
3 (11%)
2 (7%)
Index Nodal Stage
0
206 (81%)
14 (5%)
13 (5%)
0.197
47 (80%)
6 (10%)
1 (2%)
5 (8%)
40 (85%)
0 (0%)
6 (13%)
2 (100%)
Index Clinical Stage†
76 (85%)
5 (6%)
0.799
97 (78%)
14 (11%)
5 (4%)
75 (81%)
7 (8%)
45 (82%)
3 (5%)
4 (7%)
Recurrence‡
No Recurrence
147 (74%)
21 (11%)
18 (9%)
0.001
Local Recurrence Only
78 (89%)
1 (1%)
2 (2%)
Nodal Recurrence Only
39 (98%)
1 (3%)
Both Nodal and Local
31 (91%)
3 (9%)
Treatment Modality
Radiotherapy Alone
69 (85%)
3 (4%)
0.775
Surgery Alone
119 (81%)
8 (5%)
Surgery + Radiotherapy
98 (80%)
12 (10%)
7 (6%)
Radiotherapy-> Surgery
9 (69%)
1 (8%)
2 (15%)
Status
Non HNSCC death
100 (66%)
20 (13%)
11 (7%)
0.000
HNSCC death
123 (98%)
Alive
72 (84%)
6 (7%)
All Cause Death
Yes
223 (81%)
21 (8%)
20 (7%)
0.177
No